Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241030 · ClinicalTrials.gov registry record · Phase 2
Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial
A Phase 2 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 2
- Development phase
- 102
- Enrollment target
NCT03241030 is a Phase 2 study that has completed, run by University of Texas at Austin. The registered enrollment target is 102 participants.
The verdict
NCT03241030, a Phase 2 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to see if sucralfate, a medication commonly used for patients with stomach ulcers, may help pediatric patients with mouth ulcers decrease their pain level and improve their ability to drink.
Interventions
- DRUG Acetaminophen
- OTHER Placebo
- DRUG Ibuprofen
- DRUG Sucralfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2019-06-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03241030
The ClinicalTrials.gov registry entry for NCT03241030 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT03241030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03241030 about?
NCT03241030 is a clinical study titled "Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial". The purpose of this study is to see if sucralfate, a medication commonly used for patients with stomach ulcers, may help pediatric patients with mouth ulcers decrease their pain level and improve their ability to drink.
What is the current status of trial NCT03241030?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2017-09-12. Estimated completion is 2019-06-20.
What interventions are being tested in trial NCT03241030?
The interventions under investigation include: Acetaminophen (DRUG), Placebo (OTHER), Ibuprofen (DRUG), Sucralfate (DRUG).
Who is sponsoring clinical trial NCT03241030?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.